Moshe Weitzberg

Chemistry · Physical Sciences

18h-index874citations46works0.02yr avg
OpenAlex↗Google Scholar↗

Accepting Students?

No reports yet. Know if this professor is taking students?

Research Topics

Coordination Chemistry and Organometallics(7), Synthesis and Catalytic Reactions(7), Protease and Inhibitor Mechanisms(6), Peptidase Inhibition and Analysis(6), Asymmetric Synthesis and Catalysis(5)

Publications46 total

Employment Issues Related to Transition: Lessons from Aspiritech
˜The œInternational Library of Bioethics·2022
Gene Expression Analysis in Rats Treated with Experimental Acetyl-Coenzyme A Carboxylase Inhibitors Suggests Interactions with the Peroxisome Proliferator-Activated Receptor α Pathway
Journal of Pharmacology and Experimental Therapeutics·2007· 22 cited
<i>N</i>-{3-[2-(4-Alkoxyphenoxy)thiazol-5-yl]-1-methylprop-2-ynyl}carboxy Derivatives as Acetyl-CoA Carboxylase InhibitorsImprovement of Cardiovascular and Neurological Liabilities via Structural Modifications
Journal of Medicinal Chemistry·2007· 30 citedOpen Access
The synthesis and structure–activity relationship studies of selective acetyl-CoA carboxylase inhibitors containing 4-(thiazol-5-yl)but-3-yn-2-amino motif: Polar region modifications
Bioorganic & Medicinal Chemistry Letters·2006· 17 citedOpen Access
Novel Antibacterial Class:  A Series of Tetracyclic Derivatives
Journal of Medicinal Chemistry·2006· 8 cited
Synthesis and Structure−Activity Relationships of <i>N</i>-{3-[2-(4-Alkoxyphenoxy)thiazol-5-yl]-1-methylprop-2-ynyl}carboxy Derivatives as Selective Acetyl-CoA Carboxylase 2 Inhibitors.
Journal of Medicinal Chemistry·2006
Synthesis and Structure−Activity Relationships of <i>N</i>-{3-[2-(4-Alkoxyphenoxy)thiazol-5-yl]-1- methylprop-2-ynyl}carboxy Derivatives as Selective Acetyl-CoA Carboxylase 2 Inhibitors
Journal of Medicinal Chemistry·2006· 55 citedOpen Access
Naphthamidine urokinase plasminogen activator inhibitors with improved pharmacokinetic properties
Bioorganic & Medicinal Chemistry Letters·2004· 26 citedOpen Access
Interaction with the S1β-pocket of urokinase: 8-heterocycle substituted and 6,8-disubstituted 2-naphthamidine urokinase inhibitors
Bioorganic & Medicinal Chemistry Letters·2004· 28 citedOpen Access
Novel inhibitors of bacterial protein synthesis: structure–activity relationships for 1,8-naphthyridine derivatives incorporating position 3 and 4 variants
Bioorganic & Medicinal Chemistry Letters·2004· 15 cited
Identification of Novel Binding Interactions in the Development of Potent, Selective 2-Naphthamidine Inhibitors of Urokinase. Synthesis, Structural Analysis, and SAR of <i>N</i>-Phenyl Amide 6-Substitution
Journal of Medicinal Chemistry·2003· 66 citedOpen Access
Novel AntibacterialClass
Antimicrobial Agents and Chemotherapy·2003· 35 citedOpen Access
Probing Inhibitors Binding to Human Urokinase Crystals by Raman Microscopy:  Implications for Compound Screening
Biochemistry·2001· 19 cited
Species Specificity of Amidine-Based Urokinase Inhibitors
Biochemistry·2001· 30 cited
Structure-directed discovery of potent non-peptidic inhibitors of human urokinase that access a novel binding subsite
Structure·2000· 56 citedOpen Access
NPC 15669 inhibits the reversed passive Arthus reaction in rats by blocking neutrophil recruitment.
Journal of Pharmacology and Experimental Therapeutics·1992· 21 cited
N-[9H-(2,7-dimethylfluorenyl-9-methoxy)carbonyl]-l-leucine, NPC 15669, prevents neutrophil adherence to endothelium and inhibits CD 11b/CD 18 upregulation
Immunopharmacology·1992· 44 cited
NPC 15669 enhances survival and reverses leukopenia in endotoxin-treated mice
European Journal of Pharmacology·1991· 33 cited
N-(fluorenyl-9-methoxycarbonyl) amino acids, a class of antiinflammatory agents with a different mechanism of action.
Proceedings of the National Academy of Sciences·1991· 114 citedOpen Access
Erratum: N-(Fluorenyl-9-methoxy-carbonyl) amino acids, a class of antiinflammatory agents with a different mechanism of action (Proc. Natl. Acad. Sci. USA (January 1991) 88 (355-359))
1991· 11 cited
page 1 of 3Next →

Frequent Co-authors

Jochanan Blum(17), Zeev Aizenshtat(14), Bruce A. Beutel(7), Gary H. Posner(6), Todd W. Rockway(6), V. Nienaber(6), Ronald M. Burch(5), Xumiao Zhao(5), Kent D. Stewart(5), Vered Klinghofer(5), Vincent L. Giranda(5), Yu Gu(5), Richard F. Clark(5), Xiaojun Wang(5), Heidi S. Camp(5), Jenny M. Bator(4), Michael Wendt(4), Robert A. Mantei(4), Xiangdong Xu(4), Rongqi Wang(4)